Authors:
Jansen, M
Bardenheuer, W
Sorg, UR
Seeber, S
Flasshove, M
Moritz, T
Citation: M. Jansen et al., Protection of hematopoietic cells from O-6-alkylation damage by O-6-methylguanine DNA methyltransferase gene transfer: studies with different O-6-alkylating agents and retroviral backbones, EUR J HAEMA, 67(1), 2001, pp. 2-13
Authors:
Trarbach, T
Greifenberg, S
Bardenheuer, W
Elmaagacli, A
Hirche, H
Flasshove, M
Seeber, S
Moritz, T
Citation: T. Trarbach et al., Optimized retroviral transduction protocol for human progenitor cells utilizing fibronectin fragments, CYTOTHERAPY, 2(6), 2000, pp. 429-438
Authors:
Flasshove, M
Meusers, P
Schutte, J
Noppeney, R
Beelen, DW
Sohrab, S
Roggenbuck, U
Kemmeries, G
Brittinger, G
Seeber, S
Scheulen, ME
Citation: M. Flasshove et al., Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia, ANN HEMATOL, 79(10), 2000, pp. 533-542
Authors:
Flasshove, M
Leonard, JP
Bardenheuer, W
Moore, MAS
Citation: M. Flasshove et al., Increased resistance and selection in paclitaxel for peripheral blood progenitor cells following transduction with the MDR1 gene, TUMORDIAGN, 21(2), 2000, pp. 51-58
Authors:
Flasshove, M
Bardenheuer, W
Schneider, A
Hirsch, G
Bach, P
Bury, C
Moritz, T
Seeber, S
Opalka, B
Citation: M. Flasshove et al., Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene, J CANC RES, 126(7), 2000, pp. 391-399
Authors:
Bojko, P
Nowak, N
Moritz, T
Flasshove, M
Harstrick, A
Seeber, S
Citation: P. Bojko et al., Thrombopoietin serum levels at the start of mobilization, collection, and transfusion of autologous peripheral bleed stem cells, J CLIN APH, 14(2), 1999, pp. 57-62
Authors:
Dirksen, U
Moritz, T
Burdach, S
Flasshove, M
Hanenberg, H
Citation: U. Dirksen et al., Fanconi anemia and beta c deficiency-associated pulmonary alveolar proteinosis as two hereditary diseases of childhood which are potentially curable by stem cell gene therapy but require different therapeutic approaches, KLIN PADIAT, 211(4), 1999, pp. 329-335
Authors:
Eberhardt, W
Stamatis, G
Stuschke, M
Wilke, H
Muller, MR
Kolks, S
Flasshove, M
Schutte, J
Stahl, M
Schlenger, L
Budach, V
Greschuchna, D
Stuben, G
Teschler, H
Sack, H
Seeber, S
Citation: W. Eberhardt et al., Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial, BR J CANC, 81(7), 1999, pp. 1206-1212